A novel ophthalmic viscosurgical device-free phakic intraocular lens implantation makes myopic surgery safer

An-Peng Pan, Li-Jin Wen, Xu Shao, Kaijing Zhou, Qinmei Wang, Jia Qu, A‐Yong YuEye 2020 · DOI

TL;DR

This paper introduces and evaluates a novel "viscosurgical device-free" (OVD-free) method for implanting phakic intraocular lenses (PIOLs) to correct myopia. The OVD-free approach significantly reduces early postoperative intraocular pressure (IOP) spikes and shortens surgery time compared to the standard method, suggesting it's a safer and more efficient alternative.

What Problem Does This Paper Address?

Myopia, or nearsightedness, is a widespread vision disorder affecting millions globally. Phakic intraocular lens (PIOL) implantation, particularly models like the Implantable Collamer Lens (ICL), is a well-established and effective surgical solution for moderate to high myopia. However, a common complication with the standard PIOL implantation technique is a transient rise in intraocular pressure (IOP) within the first 24 hours post-surgery. This elevation is often attributed to the use of ophthalmic viscosurgical devices (OVDs), which are gel-like substances used to maintain anterior chamber stability during surgery. Besides causing IOP spikes, OVDs add to surgical time and cost, and their removal can sometimes lead to inadvertent contact between the ICL and the crystalline lens, potentially causing lens opacification. This study aims to address these issues by evaluating a new OVD-free method that utilizes specialized surgical instruments and a continuous balanced salt solution (BSS) infusion to maintain anterior chamber stability.

Methods

The study employed a retrospective cohort design, comparing two groups of myopic eyes that underwent ICL (V4c model) implantation at the Eye Hospital of Wenzhou Medical University.

  • Standard Method Group: Utilized a single side-port incision and involved the injection and subsequent irrigation of OVDs to maintain anterior chamber stability.
  • OVD-Free Method Group: Employed two side-port incisions. One was used for continuous BSS infusion to maintain the anterior chamber, while the other facilitated the insertion and manipulation of the ICL. Crucially, no OVDs were used in this group.

Key clinical data collected included intraocular pressure (IOP), corrected distance visual acuity (CDVA), and spherical equivalent (SE) at various postoperative time points (2 hours, 1 day, 1 week, and 3 months). Endothelial cell loss and other complications were also meticulously recorded. Statistical analysis involved t-tests, ANOVA with repeated measures, and Chi-squared tests to compare outcomes between the groups.

Datasets

The study utilized retrospective clinical data from 49 eyes of patients who underwent PIOL implantation. These data included preoperative demographics, surgical details, and postoperative outcomes. No new datasets or benchmarks were introduced.

Key Insights and Ideas

  • Eliminating OVDs Eliminates IOP Spikes: The most striking finding is the complete absence of early acute IOP elevation (>22 mmHg at 2 hours post-op) in the OVD-free group, directly contrasting with the 66.7% incidence in the standard group. This strongly suggests OVDs are the primary culprit for these transient, yet potentially problematic, IOP spikes.
  • Faster Visual Recovery: While both methods achieved good visual outcomes by 3 months, the OVD-free group showed significantly better CDVA at 1 day and 1 week post-surgery. This hints at a faster initial visual recovery, possibly due to a less inflamed or more stable anterior chamber environment.
  • Shorter Surgical Times: The OVD-free method consistently resulted in shorter operation times, a direct benefit for both patients and surgeons, reducing chair time and potential costs associated with longer procedures.
  • Safety Without Compromise: The study found no significant difference in endothelial cell loss or other serious complications (like pupillary block or cataract formation) between the groups over the 3-month follow-up. This indicates that removing OVDs does not compromise the safety of the procedure in terms of these critical metrics.

Key Results

  • IOP Elevation: 66.7% of eyes in the standard group experienced IOP > 22 mmHg at 2 hours post-op, compared to 0% in the OVD-free group (p < 0.001). The mean IOP increase at 2 hours was significantly higher in the standard group (10.5 mmHg) versus the OVD-free group (2.2 mmHg).
  • Visual Acuity (CDVA): The OVD-free group showed significantly better LogMAR CDVA at 1 day (p=0.012) and 1 week (p=0.03), though not at 3 months (p=0.134).
  • Spherical Equivalent (SE): No significant difference in the time course of SE changes was observed between the groups (p=0.524).
  • Endothelial Cell Loss: In the OVD-free group, mean endothelial cell loss was 4.6% at 3 months, which was comparable to findings in literature using standard methods.
  • Operation Time: The OVD-free method was significantly shorter (p < 0.001).

Limitations and Future Work

The authors acknowledge several limitations:

  • Retrospective Design: The study was retrospective, meaning patients were not randomly assigned to groups, which can introduce bias.
  • Small Sample Size: The study included only 49 eyes, which is a relatively small sample.
  • Incomplete Data: Postoperative endothelial cell density was only available for the OVD-free group, and anterior chamber vaults were not completely quantified for all eyes.

To address these limitations and further validate the findings, the authors have initiated a "Prospective, Multicenter, Randomized Clinical Investigation of a Viscoelastic-free Method for Implantable Collamer Lens (ICL) Implantation to Treat High Myopia: A Pilot Study." This future work aims to provide more robust evidence on the efficacy and safety of the OVD-free method through randomization, larger sample sizes, and comprehensive data collection, including anterior segment optical coherence tomography for vault measurements.

Summary updated

Abstract

The OVD-free method is safe and efficient for ICL implantation. It can be a safer method of ICL implantation compared to the standard method in that it completely eliminates ophthalmic viscoelastic devices-related complications without causing additional complications.
BibTeX
@inproceedings{pan2020novel,
  author = {An-Peng Pan and Li-Jin Wen and Xu Shao and Kaijing Zhou and Qinmei Wang and Jia Qu and A‐Yong Yu},
  title = {{A novel ophthalmic viscosurgical device-free phakic intraocular lens implantation makes myopic surgery safer}},
  booktitle = {Eye},
  year = {2020},
  doi = {10.1186/s40662-020-00185-4},
}
Figure